SAKAR HEALTHCARE
|
The Current P/E Ratio of SAKAR HEALTHCARE is 40.76.
| Share Price | ₹361.2 | Oct 31,2025 |
| Market Cap | ₹805.5 Cr | |
| Earnings-TTM | ₹19.8 Cr | TTM-Consolidated Results |
| Price/Earnings | 40.76x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹805.5 Cr] as on Oct 31,2025
(/) Earnings [ ₹19.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 40.76x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 40.76 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE
PE Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 27.63x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 16.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 68.64x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 7.77x.
How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SAKAR HEALTHCARE | 19.76 | 40.76 | 805.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.94 | 405,452.0 |
| DIVIS LABORATORIES LTD | 2,306.00 | 77.66 | 179,089.0 |
| CIPLA LTD | 5,453.86 | 22.24 | 121,299.0 |
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.17 | 120,456.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.47 | 99,965.9 |
| MANKIND PHARMA LTD | 1,905.51 | 51.60 | 98,333.5 |
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.14 | 98,057.5 |
| LUPIN LTD | 3,722.18 | 24.10 | 89,719.5 |
| AUROBINDO PHARMA LTD | 3,417.93 | 19.35 | 66,133.0 |
| ABBOTT INDIA LTD | 1,452.29 | 42.44 | 61,629.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.47x |
| Max industry PE | 77.66x |
| Median industry PE | 38.94x |
| Average industry PE | 37.81x |
You may also like the below Video Courses